CVM SCIENTISTS WIN AWARDS - July/August 2002

FDA Veterinarian Newsletter 2002 Volume XVI, No IV

At the 2002 FDA Scientific Achievement Awards Ceremony, held on February 21, 2002, the following CVM scientists were recognized:

• EXCELLENCE IN ANALYTICAL SCIENCE
  Raafat Fahmy, Ph.D. - For excellence in developing novel methods for the dissolution of aspirin, sulfas and tetracycline boluses, a unique dosage form, using standard USP apparatus and environmentally sound solvents.
• EXCELLENCE IN LABORATORY SCIENCE
  Patrick F. McDermott, Ph.D. - For demonstrating the impact the use of fluoroquinolones in chickens has on the selection for fluoroquinolone resistant Campylobacter.
• EXCELLENCE IN REVIEW SCIENCE
  Tania Denise Woerner, V.M.D. - Dr. Woerner utilized a novel approach to corroborate the findings of a clinical study for the approval of ponazuril to treat Equine Protozoal Myeloencephalitis (EPM).

• OUTSTANDING INTER-CENTER SCIENTIFIC COLLABORATION
  Phenylbutazone Residue Group - ORA
  Denver District Laboratory

  • Karen S. Kreuzer
  • Mark R. Madson
  • Sherri B. Turnipseed, Ph.D.
  • Susan B. Clark
  • Gene J. Nandrea
  • William B. Martin, Ph.D.
  • W. Douglas Rowe
  • Lara L. Murphy
  • John N. Sofos

  
  Seattle Regional Laboratory

  • Jeffrey A. Hurlbut, Ph.D.

  CVM

  • Deborah A. Cera
  • John O'Rangers, Ph.D.
  • Michael H. Thomas
  • Mary C. Carson, Ph.D.
  • David N. Heller

For protection of the Public's Health through the reduction of Phenylbutazone abuse in food-producing animals through analytical surveillance, education and regulatory actions.

CVM is proud of these accomplishments and congratulates all FDA award winners.